Medicines and Healthcare products Regulatory Agency
Regulatory Agency
- MHRA guidance on Coronavirus (COVID-19)
- Drug and device alerts
- Drug Safety Update
- Yellow Card: Report a problem with a medicine or medical device
- Blood regulation and safety
- Marketing authorisations and licensing guidance
- Patient information leaflets and summaries of product characteristics
- Public assessment reports
- Medical devices regulation and safety
- Contact MHRA
- All MHRA services and information
Featured
Collection
MHRA guidance on coronavirus (COVID-19)
We are producing guidance and information for industry, healthcare professionals and patients covering the coronavirus (COVID-19) outbreak.
News story
Action taken to halt sales of fingerprick coronavirus (COVID-19) antibody testing kits
Anyone supplying these types of tests should temporarily stop this service.
Guidance
How tests and testing kits for coronavirus (COVID-19) work
The different types of tests and testing kits for COVID-19, and the specifications for manufacturers.
Press release
MHRA issues a scientific opinion for the first medicine to treat COVID-19 in the UK
MHRA has today given the first positive scientific opinion under the Early Access to Medicines Scheme (EAMS) for use of Gilead’s remdesivir.
Detailed guide
MHRA regulatory flexibilities resulting from coronavirus (COVID-19)
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Press release
Patients informed to exchange Emerade 500 micrograms adrenaline pens for a different brand
Allergy patients who carry Emerade 500 microgram adrenaline auto-injector pens should contact their prescriber and seek replacement pens of a different brand.
Latest from the Medicines and Healthcare products Regulatory Agency
What the Medicines and Healthcare products Regulatory Agency does
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health and Social Care.
Follow us
Documents
Policy papers and consultations
- How should we engage and involve patients and the public in our work
- MHRA consultation on EU exit no-deal legislative proposals
Transparency and freedom of information releases
- Medicines and Healthcare products Regulatory Agency GPC spending over £500: 2019 - 2020
- MHRA: requests under the Freedom of Information Act (FOIA)
Our management
Contact MHRA
General enquiries
10 South Colonnade
London
E14 4PU
United Kingdom
Telephone
020 3080 6000
Fax
020 3118 9803
Please get in touch with us by phone or email during the coronavirus (COVID-19) response period.
In line with the Government’s advice, our building at 10 South Colonnade closed at 5pm on Friday 27 March.
Office hours are Monday to Friday, 9am to 5pm.
We are open for emergency only COVID-19 and regulatory flexibilities queries over weekends.
Please call 020 3080 6725 or email info@mhra.gov.uk between 09:00 and 17:00.
We will also take out of hours emergency calls on COVID-19 and regulatory flexibilities on this number, from 17:00 to 23:00 during the weekend.
Media enquiries
MHRA
10 South Colonnade
London
E14 4PU
United Kingdom
During office hours:
020 3080 7651 (08:30 - 17:00)
Out of office hours:
07770 446 189 (17:00 - 08:30)
Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at https://www.twitter.com/mhrapress
Make an FOI request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of Information
Corporate information
Jobs and contracts